Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Giménez-Xavier

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|April 1, 2006
The decrease of NAD(P)H has a prominent role in dopamine toxicityP Giménez-Xavier, C Gómez-Santos, E Castaño, et al.
ESMO Open|October 17, 2025
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapyR Gómez-Bravo, B Walbaum, M Bergamino, et al.
ESMO Open|September 25, 2025
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancerB Walbaum, O Martínez-Sáez, F Brasó-Maristany, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|April 1, 2006
The decrease of NAD(P)H has a prominent role in dopamine toxicityP Giménez-Xavier, C Gómez-Santos, E Castaño, et al.
ESMO Open|October 17, 2025
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapyR Gómez-Bravo, B Walbaum, M Bergamino, et al.
ESMO Open|September 25, 2025
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancerB Walbaum, O Martínez-Sáez, F Brasó-Maristany, et al.
Pageof 1